INTRANASAL FORMULATION FOR THE TREATMENT OF CARDIOPULMONARY RESUSCITATION (CPR), CARDIAC LIFE SUPPORT (CLS), ANAPHYLAXIS AND/OR ANAPHYLACTOID REACTIONS

摘要

Disclosed herein are dry powder compositions and unit doses that comprise vasoactive agents, and/or anti-anaphylactic and/or anti-anaphylactoid agents suitable for intranasal administration, methods of making the compositions, and methods of using the compositions to treat disorders, for example anaphylaxis, anaphylactoid reactions, bronchospasm, cardiac arrest, hypotensive shock, or other situations requiring the need to implement cardiopulmonary resuscitation (CPR) and/or basic or advanced cardiac life support (ACLS).